Encephalopathy cost-effectiveness of therapy

Encephalopathy
Home
Patient Information
Overview
Classification
Pathophysiology
Causes
Differentiating Encephalopathy from other Diseases
Epidemiology & Demographics
Risk Factors
Screening
Natural History, Complications & Prognosis
Diagnosis
Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Electroencephalogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Encephalopathy cost-effectiveness of therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Encephalopathy cost-effectiveness of therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Encephalopathy cost-effectiveness of therapy
CDC on Encephalopathy cost-effectiveness of therapy
Encephalopathy cost-effectiveness of therapy in the news
Blogs on Encephalopathy cost-effectiveness of therapy
Directions to Hospitals Treating Encephalopathy
Risk calculators and risk factors for Encephalopathy cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]

Financial Costs

• Cost effectiveness of various therapies depends on the condition.
• Hypothermia - Neonatal Encephalopathy - The incremental cost per disability-free life year gained was US$28,124 (£19,931 ; €26,920) as per the data of 2006 Organisation for Economic Co-operation and Development (OECD).